B
L. E. Bermudez, Wu, M., and Young, L. S.,
“Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin.”,
The Journal of infectious diseases, vol. 156, no. 3, pp. 510-3, 1987.
L. E. Bermudez and Inderlied, C. B.,
“Effect of Mycobacterium avium infection on the influx, accumulation, and efflux of KRM-1648 by human macrophages.”,
Microbial drug resistance (Larchmont, N.Y.), vol. 3, no. 3, pp. 277-82, 1997.
L. E. Bermudez, Petrofsky, M., Inderlied, C. B., and Young, L. S.,
“Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice.”,
The Journal of antimicrobial chemotherapy, vol. 36, no. 4, pp. 641-6, 1995.
L. E. Bermudez, Parker, A., and Petrofsky, M.,
“Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases.”,
Clinical and experimental immunology, vol. 116, no. 1, pp. 94-9, 1999.
L. E. Bermudez,
“Potential role of cytokines in disseminated mycobacterial infections.”,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 13 Suppl 2, pp. S29-33, 1994.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Chee, C. B., Aralar, P., Petrofsky, M., Parman, T., Green, C. E., Lewin, A. H., Ellis, W. Y., and Young, L. S.,
“Identification of (+)-Erythro-Mefloquine as an Active Enantiomer with Greater Efficacy than Mefloquine against Mycobacterium avium Infection in Mice.”,
Antimicrobial agents and chemotherapy, vol. 56, no. 8, pp. 4202-6, 2012.
L. E. Bermudez, Petrofsky, M., Sommer, S., and Barletta, R. G.,
“Peyer's patch-deficient mice demonstrate that Mycobacterium avium subsp. paratuberculosis translocates across the mucosal barrier via both M cells and enterocytes but has inefficient dissemination.”,
Infection and immunity, vol. 78, no. 8, pp. 3570-7, 2010.
L. E. Bermudez,
“[Bacteremias in immunosuppressed patients].”,
Revista paulista de medicina, vol. 104, no. 2, pp. 87-92, 1986.
L. E. Bermudez, Young, L. S., and Enkel, H.,
“Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins.”,
Infection and immunity, vol. 59, no. 5, pp. 1697-702, 1991.
L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S.,
“Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy.”,
Antimicrobial agents and chemotherapy, vol. 42, no. 1, pp. 180-3, 1998.
L. E. Bermudez, Martinelli, J., Petrofsky, M., Kolonoski, P., and Young, L. S.,
“Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model.”,
The Journal of infectious diseases, vol. 169, no. 3, pp. 575-80, 1994.
L. E. Bermudez, Nash, K., Petrofsky, M., Young, L. S., and Inderlied, C. B.,
“Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice.”,
Antimicrobial agents and chemotherapy, vol. 44, no. 10, pp. 2619-22, 2000.
L. E. Bermudez, Wagner, D., and Sosnowska, D.,
“Mechanisms of Mycobacterium avium pathogenesis.”,
Archivum immunologiae et therapiae experimentalis, vol. 48, no. 6, pp. 521-7, 2000.
L. E. Bermudez, Kolonoski, P., and Young, L. S.,
“Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.”,
Antimicrobial agents and chemotherapy, vol. 40, no. 4, pp. 1033-5, 1996.
L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S.,
“An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract.”,
The Journal of infectious diseases, vol. 165, no. 1, pp. 75-9, 1992.
L. E. Bermudez, Wu, M., and Young, L. S.,
“Effect of stress-related hormones on macrophage receptors and response to tumor necrosis factor.”,
Lymphokine research, vol. 9, no. 2, pp. 137-45, 1990.